These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32273232)

  • 21. Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI).
    Amann B; Lüdemann C; Rückert R; Lawall H; Liesenfeld B; Schneider M; Schmidt-Lucke J
    Vasa; 2008 Nov; 37(4):319-25. PubMed ID: 19003741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 3-month Safety Assessment of Human Bone Marrow Derived Mesenchymal Stromal Cells Administered Once by the Intramuscular Route to Immunodeficient Mice.
    Creane M; McElroy M; Duffy A; Dawood CS; O'Brien T
    Toxicol Pathol; 2018 Apr; 46(3):290-301. PubMed ID: 29504494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intra-arterial allogeneic mesenchymal stem cells for critical limb ischemia are safe and efficacious: report of a phase I study.
    Das AK; Bin Abdullah BJ; Dhillon SS; Vijanari A; Anoop CH; Gupta PK
    World J Surg; 2013 Apr; 37(4):915-22. PubMed ID: 23307180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Autologous Cell-based Therapy in Patients with No-option Critical Limb Ischaemia: A Meta-Analysis.
    Wahid FSA; Ismail NA; Wan Jamaludin WF; Muhamad NA; Mohamad Idris MA; Lai NM
    Curr Stem Cell Res Ther; 2018; 13(4):265-283. PubMed ID: 29532760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of the Naples and Pietra Ligure Evaluation of Stem Cells study.
    Schiavetta A; Maione C; Botti C; Marino G; Lillo S; Garrone A; Lanza L; Pagliari S; Silvestroni A; Signoriello G; Sica V; Cobellis G
    Stem Cells Transl Med; 2012 Jul; 1(7):572-8. PubMed ID: 23197862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human bone marrow-derived, pooled, allogeneic mesenchymal stromal cells manufactured from multiple donors at different times show comparable biological functions in vitro, and in vivo to repair limb ischemia.
    Thej C; Balasubramanian S; Rengasamy M; Walvekar A; Swamynathan P; Raj SS; Shahani P; Siddikuzzaman ; Kolkundkar U; Seetharam RN; Gupta PK; Majumdar AS
    Stem Cell Res Ther; 2021 May; 12(1):279. PubMed ID: 33971964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies.
    Rigato M; Monami M; Fadini GP
    Circ Res; 2017 Apr; 120(8):1326-1340. PubMed ID: 28096194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial.
    Gabr H; Hedayet A; Imam U; Nasser M
    Exp Clin Transplant; 2011 Jun; 9(3):197-202. PubMed ID: 21649569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia.
    Gupta PK; Chullikana A; Parakh R; Desai S; Das A; Gottipamula S; Krishnamurthy S; Anthony N; Pherwani A; Majumdar AS
    J Transl Med; 2013 Jun; 11():143. PubMed ID: 23758736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial.
    Ohtake T; Mochida Y; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Higashide S; Ioji T; Fujita Y; Kawamoto A; Fukushima M; Kobayashi S
    Stem Cells Transl Med; 2018 Nov; 7(11):774-782. PubMed ID: 30059194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical presentation and outcome after failed infrainguinal endovascular and open revascularization in patients with chronic limb ischemia.
    Dosluoglu HH; Lall P; Blochle R; Harris LM; Dryjski ML
    J Vasc Surg; 2013 Jul; 58(1):98-104.e1. PubMed ID: 23683380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia.
    Shirbaghaee Z; Hassani M; Heidari Keshel S; Soleimani M
    Stem Cell Res Ther; 2022 Sep; 13(1):462. PubMed ID: 36068595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of the Long-term Effects of Autologous Bone-Marrow Mononuclear Cell Implantation on Clinical Outcomes in Patients with Critical Limb Ischemia.
    Yusoff FM; Kajikawa M; Matsui S; Hashimoto H; Kishimoto S; Maruhashi T; Chowdhury M; Noma K; Nakashima A; Kihara Y; Sueda T; Higashi Y
    Sci Rep; 2019 May; 9(1):7711. PubMed ID: 31118440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of mesenchymal stem cells of "no-options" patients with critical limb ischemia treated by autologous bone marrow mononuclear cells.
    Altaner C; Altanerova V; Cihova M; Hunakova L; Kaiserova K; Klepanec A; Vulev I; Madaric J
    PLoS One; 2013; 8(9):e73722. PubMed ID: 24069226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials.
    Peeters Weem SM; Teraa M; de Borst GJ; Verhaar MC; Moll FL
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):775-83. PubMed ID: 26460286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia: The SPINACH Study (Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia).
    Iida O; Takahara M; Soga Y; Kodama A; Terashi H; Azuma N;
    Circ Cardiovasc Interv; 2017 Dec; 10(12):e005531. PubMed ID: 29246911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous bone marrow mononuclear cell therapy for critical limb ischemia is effective and durable.
    Liang TW; Jester A; Motaganahalli RL; Wilson MG; G'Sell P; Akingba GA; Fajardo A; Murphy MP
    J Vasc Surg; 2016 Jun; 63(6):1541-5. PubMed ID: 27021379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Netrin-1 with stem cells promote angiogenesis in limb ischemic rats.
    Chen T; Chen D; Li F; Tan Z
    J Surg Res; 2014 Dec; 192(2):664-9. PubMed ID: 25240286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Midterm Outcomes From a Pilot Study of Percutaneous Deep Vein Arterialization for the Treatment of No-Option Critical Limb Ischemia.
    Kum S; Tan YK; Schreve MA; Ferraresi R; Varcoe RL; Schmidt A; Scheinert D; Mustapha JA; Lim DM; Ho D; Tang TY; Alexandrescu VA; Mutirangura P
    J Endovasc Ther; 2017 Oct; 24(5):619-626. PubMed ID: 28697694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Participation in a Chronic Limb Threatening Ischemia Randomized Trial Is Inversely Correlated With Regional Amputation Rate in Limb Threatening Ischemia Patients.
    Siracuse JJ; Goodney PP; Menard MT; Rosenfield K; Van Over M; Hamza TH; Eid M; Villarreal MF; Strong MB; Farber A
    Ann Surg; 2021 Oct; 274(4):621-626. PubMed ID: 34506317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.